These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30623424)

  • 21. Topically administered fluorouracil in acrodermatitis continua of Hallopeau.
    Tsuji T; Nishimura M
    Arch Dermatol; 1991 Jan; 127(1):27-8. PubMed ID: 1986705
    [No Abstract]   [Full Text] [Related]  

  • 22. Apremilast as therapeutic option in a HIV positive patient with severe psoriasis.
    Sacchelli L; Patrizi A; Ferrara F; Bardazzi F
    Dermatol Ther; 2018 Nov; 31(6):e12719. PubMed ID: 30358044
    [No Abstract]   [Full Text] [Related]  

  • 23. Lack of efficacy of etanercept in acrodermatitis continua of Hallopeau.
    Adişen E; Oztaş M; Gürer MA
    Int J Dermatol; 2007 Nov; 46(11):1205-7. PubMed ID: 17988345
    [No Abstract]   [Full Text] [Related]  

  • 24. Acrodermatitis continua of Hallopeau (ACH): two cases successfully treated with adalimumab.
    Di Costanzo L; Napolitano M; Patruno C; Cantelli M; Balato N
    J Dermatolog Treat; 2014 Dec; 25(6):489-94. PubMed ID: 24215490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short- and Long-Term Management of an Acute Pustular Psoriasis Flare: A Case Report.
    Georgakopoulos JR; Ighani A; Yeung J
    J Cutan Med Surg; 2017; 21(5):452-456. PubMed ID: 28535721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acrodermatitis continua of Hallopeau: treatment with etretinate and review of relapsing pustular eruptions of the hands and feet.
    Pearson LH; Allen BS; Smith JG
    J Am Acad Dermatol; 1984 Oct; 11(4 Pt 2):755-62. PubMed ID: 6491002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Progression of Acrodermatitis Continua of Hallopeau With Baricitinib.
    Han GM; Yang WS; Yang B
    JAMA Dermatol; 2021 Apr; 157(4):466-468. PubMed ID: 33656520
    [No Abstract]   [Full Text] [Related]  

  • 28. [PUVA-bath photochemotherapy in Hallopeau's acrodermatitis continua suppurativa].
    Behrens S; von Kobyletzki G; Hoffmann K; Altmeyer P; Kerscher M
    Hautarzt; 1997 Nov; 48(11):824-7. PubMed ID: 9518245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apremilast, beyond psoriasis as a therapeutic target.
    Ruiz-Villaverde R; Bueno-Rodriguez A; Tercedor-Sánchez J
    Med Clin (Barc); 2017 Jul; 149(1):42-43. PubMed ID: 28242122
    [No Abstract]   [Full Text] [Related]  

  • 30. Apremilast in Treatment-Refractory Recurrent Aphthous Stomatitis.
    Kolios AGA; Yawalkar N; Feusi A; Kündig T; Boyman O; Nilsson J
    N Engl J Med; 2019 Nov; 381(20):1975-1977. PubMed ID: 31722161
    [No Abstract]   [Full Text] [Related]  

  • 31. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of hallopeau.
    Kazinski K; Joyce KM; Hodson D
    J Drugs Dermatol; 2005; 4(3):360-4. PubMed ID: 15898294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apremilast and phototherapy for treatment of psoriasis in a patient with human immunodeficiency virus.
    Reddy SP; Lee E; Wu JJ
    Cutis; 2019 May; 103(5):E6-E7. PubMed ID: 31233584
    [No Abstract]   [Full Text] [Related]  

  • 33. Improvement of recalcitrant Sneddon-Wilkinson disease with apremilast.
    Magdaleno-Tapial J; Valenzuela-Oñate C; Alonso-Carpio M; García-Legaz M; Alegre-de Miquel V; Zaragoza-Ninet MG; Zaragoza-Ninet V
    Australas J Dermatol; 2020 May; 61(2):185-186. PubMed ID: 32048271
    [No Abstract]   [Full Text] [Related]  

  • 34. Apremilast for treatment of recurrent erythema multiforme.
    Chen T; Levitt J; Geller L
    Dermatol Online J; 2017 Jan; 23(1):. PubMed ID: 28329479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful Treatment of Refractory Type 1 Pityriasis Rubra Pilaris With Apremilast.
    Molina-Figuera E; González-Cantero Á; Martínez-Lorenzo E; Sánchez-Moya AI; García-Olmedo O; Gómez-Dorado B; Schoendorff-Ortega C
    J Cutan Med Surg; 2018; 22(1):104-105. PubMed ID: 29309244
    [No Abstract]   [Full Text] [Related]  

  • 36. Apremilast for a psoriasis patient with HIV and hepatitis C.
    Reddy SP; Shah VV; Wu JJ
    J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):e481-e482. PubMed ID: 28449227
    [No Abstract]   [Full Text] [Related]  

  • 37. A Case of Pityriasis Rubra Pilaris Treated Successfully with the Phosphodiesterase-4 Inhibitor Apremilast.
    Cho M; Honda T; Ueshima C; Kataoka T; Otsuka A; Kabashima K
    Acta Derm Venereol; 2018 Nov; 98(10):975-976. PubMed ID: 29944172
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of Apremilast in Patients with Prurigo Nodularis: A Proof-of-concept Study.
    Todberg T; Skov L; Simonsen S; Kainu K; Zachariae C
    Acta Derm Venereol; 2020 Apr; 100(8):adv00118. PubMed ID: 32189005
    [No Abstract]   [Full Text] [Related]  

  • 39. Hallopeau's acrodermatitis continua of the nail apparatus: a clinical and pathological study of 20 patients.
    Piraccini BM; Fanti PA; Morelli R; Tosti A
    Acta Derm Venereol; 1994 Jan; 74(1):65-7. PubMed ID: 7908489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses.
    Abrouk M; Farahnik B; Zhu TH; Nakamura M; Singh R; Lee K; Lucking SM; Blossom J; Liao W; Koo J; Bhutani T; Shinkai K; Nguyen T
    J Am Acad Dermatol; 2017 Jul; 77(1):177-180. PubMed ID: 28619562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.